TotalMarketCap

Innoviva

INVANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.366 B

$19.22 -9.62%

Close of 6 Nov 2026

As of 6 Nov 2026, Innoviva (INVA) has a market capitalization of $1.37B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$411.3M

#1992 by revenue

Earnings

—

Not reported

Shares outstanding

71,081,477

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #122ADARx PharmaceuticalsADRX$1.41B
  2. #123Korsana BiosciencesKRSA$1.38B
  3. #124InnovivaINVA$1.37B
  4. #125Structure TherapeuticsGPCR$1.35B
  5. #126Damora TherapeuticsDMRA$1.35B

What if Innoviva were worth as much as…

Open the what-if tool →

Gold $28.2T

$397,246.58

Per share 20,674× higher

Bitcoin $1.53T

$21,494.32

Per share 1,119× higher

Apple $5.02T

$70,563.85

Per share 3,672× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Innoviva are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.